Healthcare - Cancer Research

Watchlist

Cancer research includes companies engaged in scientific research on the causes, prevention, diagnosis, treatment, and potential cures for cancer. It involves many disciplines, from biology and genetics to clinical trials and drug development. These companies produce life-saving products for a rapidly growing and highly sought-after market and form strategic partnerships with global organizations. This makes them appealing to investors seeking both financial gain and support for healthcare advancements and patient outcomes.

  • 968.976
  • -3.067-0.32%
20min DelayNot Open Feb 28 16:00 AET
977.031High963.349Low
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
MSBMesoblast Ltd
2.5200.060+2.44%9.86M24.89M2.4702.4602.6102.4703.21B1.85B1.28B735.94M-5.26%-10.00%-20.50%+44.83%+159.79%+754.24%-18.71%--1.34%0.00Loss5.69%Biotechnology
IMMImmutep Ltd
0.3100.005+1.64%2.95M913.37K0.3100.3050.3170.300450.92M388.10M1.45B1.25B+1.64%-4.62%-10.14%-3.13%-23.46%-11.43%-15.07%--0.24%0.00Loss5.57%Biotechnology
CSLCSL Ltd
260.5700.280+0.11%1.70M443.71M260.410260.290262.000259.500126.17B126.10B484.21M483.95M+0.73%+1.43%-7.08%-7.15%-13.26%-6.66%-7.46%1.42%0.35%31.8931.890.96%Biotechnology
CUVClinuvel Pharmaceuticals Ltd
11.490-0.260-2.21%1.71M19.62M11.90011.75012.03011.360575.20M475.34M50.06M41.37M+1.86%+0.79%-5.04%-11.89%-21.03%-17.48%-4.73%0.44%4.12%15.0016.465.70%Biotechnology
IMUImugene Ltd
0.037-0.001-2.63%10.30M385.92K0.0380.0380.0390.037280.32M231.64M7.58B6.26B-2.63%-13.95%+2.78%-2.63%-30.19%-67.83%0.00%--0.16%LossLoss5.26%Biotechnology
TLXTelix Pharmaceuticals Ltd
28.460-1.920-6.32%9.25M265.31M28.98030.38029.25027.5209.53B7.90B334.72M277.60M-5.51%+5.10%-3.00%+15.93%+62.17%+139.97%+15.64%--3.33%196.28196.285.70%Biotechnology

News

Comments

Read more